A review of nutrition in Duchenne muscular dystrophy

Journal of Human Nutrition and Dietetics

Volumn 22, Issue 5, 2009, Pages 383-393

  Davidson, Z E ^a,b   Truby, H ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Duchenne; Evidence based dietary treatment; Muscular dystrophy; Nutrition therapy; Paediatric dietetics

Indexed keywords

25 HYDROXYVITAMIN D; ARGININE; CREATINE; CREATININE; DEFLAZACORT; GLUCOCORTICOID; GLUTAMINE; PLACEBO; PREDNISOLONE; PREDNISONE;

BODY COMPOSITION; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; BONE TURNOVER; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CREATININE URINE LEVEL; DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; DUCHENNE MUSCULAR DYSTROPHY; ENERGY CONSUMPTION; ENERGY EXPENDITURE; ENTERIC FEEDING; GASTROTOMY; HUMAN; MALNUTRITION; NEUROMUSCULAR DISEASE; NONHUMAN; NUTRIENT CONTENT; NUTRITIONAL ASSESSMENT; NUTRITIONAL DISORDER; NUTRITIONAL REQUIREMENT; OBESITY; PHYSICAL ACTIVITY; REVIEW; SHORT STATURE; SIDE EFFECT; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

CALCIUM; CHILD; CREATINE; DIETARY SUPPLEMENTS; HUMANS; MALE; MALNUTRITION; MUSCULAR DYSTROPHY, DUCHENNE; NUTRITION THERAPY; NUTRITIONAL REQUIREMENTS; OBESITY; STEROIDS; VITAMIN D;

EID: 70149093185     PISSN: 09523871     EISSN: 1365277X     Source Type: Journal    
DOI: 10.1111/j.1365-277X.2009.00979.x     Document Type: Review

References (86)

1. Aitkens, S., Kilmer, D.D., Wright, N.C. & McCrory, M.A. (2005) Metabolic syndrome in neuromuscular disease. Arch. Phys. Med. Rehab. 86, 1030-1036.
2. Almond, S., Allott, L. & Hall, K. (2007) Feeding children with neurodisabilities. In Clinical Paediatric Dietetics, 3rd edn. eds V. Shaw & M. Lawson, pp. 566-587. Carlton, Victoria: Blackwell Publishing.
3. Angelini, C. (2007) The role of corticosteroids in muscular dystrophy: A critical appraisal. Muscle Nerve 36, 424-435.
4. Backhouse, M. & Harding, L. (2006) Do males diagnosed with Duchenne muscular dystrophy (DMD) unnecessarily suffer bowel and bladder problems? Aust. N. Z. Cont. J. 12, 66-73.
5. Balaban, B., Matthews, D.J., Clayton, G.H. & Carry, T. (2005) Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: Long-term effect. Am. J. Phys. Med. Rehab. 84, 843-850.
6. Barohn, R.J., Levine, E.J., Olson, J.O. & Mendell, J.R. (1988) Gastric hypomotility in Duchenne's muscular dystrophy. New Engl. J. Med. 319, 15-18.
7. Bensen, E.S., Jaffe, K.M. & Tarr, P.I. (1996) Acute gastric dilatation in Duchenne muscular dystrophy: A case report and review of the literature. Arch. Phys. Med. Rehab. 77, 512-514.
8. Berardinelli, A., Gorni, K., Orcesi, S., Tagliabue, A., Uggetti, C. & Lanzi, G. (2001) Dystrophinopathies: Peculiar clinical and laboratory aspects. Funct. Neurol. 16, 255-262.
9. Biggar, W.D., Harris, V.A., Eliasoph, L. & Alman, B. (2006) Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul. Disord. 16, 249-255.
10. Birnkrant, D.J., Ferguson, R.D., Martin, J.E. & Gordon, G.J. (2006) Noninvasive ventilation during gastrostomy tube placement in patients with severe Duchenne muscular dystrophy: Case reports and review of the literature. Pediatr. Pulm. 41, 188-193.
11. Blake, D.J., Weir, A., Newey, S.E. & Davies, K.E. (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82, 291-329.
12. Bodamer, O.A.F., Hoffmann, G.F., Visser, G.H., Janecke, A., Linderkamp, O., Leonard, J.V., Fasoli, L. & Rating, D. (1997) Assessment of energy expenditure in metabolic disorders. Eur. J. Pediatr. Suppl. 156, S24-S28.
13. Bonifati, M.D., Ruzza, G., Bonometto, P., Berardinelli, A., Gorni, K., Orcesi, S., Lanzi, G. & Angelini, C. (2000) A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve 23, 1344-1347.
14. Borrelli, O., Salvia, G., Mancini, V., Santoro, L., Tagliente, F., Romeo, E.F. & Cucchiara, S. (2005) Evolution of gastric electrical features and gastric emptying in children with Duchenne and Becker muscular dystrophy. Am. J. Gastroenterol. 100, 695-702.
15. Buetler, T.M., Renard, M., Offord, E.A., Schneider, H. & Ruegg, U.T. (2002) Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am. J. Clin. Nutr. 75, 749-753.
16. Bushby, K., Bourke, J., Bullock, R., Eagle, M., Gibson, M. & Quinby, J. (2005) The multidisciplinary management of Duchenne muscular dystrophy. Curr. Paediatr. 15, 292-300.
17. Canalis, E., Bilezikian, J.P., Angeli, A. & Giustina, A. (2004) Perspectives on glucocorticoid-induced osteoporosis. Bone 34, 593-598.
18. Cano, N.J.M., Roth, H., Court-Fortune, I., Cynober, L., Gerard-Boncompain, M., Cuvelier, A., Laaban, J.P., Melchior, J.C., Pichard, C., Raphael, J.C. & Pison, C.M. (2002) Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation. Eur. Respir. J. 20, 30-37.
19. Carter, G.T., Yudkowsky, M.P., Han, J.J. & McCrory, M.A. (2005) Topiramate for weight reduction in duchenne muscular dystrophy. Muscle Nerve 31, 788-789.
20. Chaubourt, E., Fossier, P., Baux, G., Leprince, C., Israel, M. & De La Porte, S. (1999) Nitric oxide and L-arginine cause an accumulation of utrophine at the sarcolemma: A possible compensation for dystrophin loss in Duchenne muscular dystrophy. Neurobiol. Dis. 6, 499-507.
21. Daftary, A.S., Crisanti, M., Kalra, M., Wong, B. & Amin, R. (2007) Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy. Pediatrics 119, e320-e324.
22. Darmaun, D., Welch, S., Rini, A., Sager, B.K., Altomare, A. & Haymond, M.W. (1998) Phenylbutyrate-induced glutamine depletion in humans: Effect on leucine metabolism. Am. J. Physiol. 274, E801-E807.
23. Department of Health (1991) Report 41: Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. London: The Stationery Office.
24. Desilva, S., Drachman, D.B., Mellits, D. & Kuncl, R.W. (1987) Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. Arch. Neurol. 44, 818-822.
25. Dorchies, O.M., Wagner, S., Vuadens, O., Waldhauser, K., Buetler, T.M., Kucera, P. & Ruegg, U.T. (2006) Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am. J. Physiol. Cell Physiol. 290, C616-C625.
26. Douvillez, B., Braillon, P., Hodgkinson, I. & Berard, C. (2005) Pain, ostropenia and body composition of 22 patients with Duchenne muscular dystrophy: A descriptive study. Ann. Readapt. Med. Phys. 48, 616-622.
27. Eagle, M., Baudouin, S.V., Chandler, C., Giddings, D.R., Bullock, R. & Bushby, K. (2002) Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul. Disord. 12, 926-929.
28. Edmonds, C.J., Smith, T., Griffiths, R.D., Mackenzie, J. & Edwards, R.H. (1985) Total body potassium and water, and exchangeable sodium in muscular dystrophy. Clin. Sci. 68, 379-385.
29. Edwards, R.H., Round, J.M., Jackson, M.J., Griffiths, R.D. & Lilburn, M.F. (1984) Weight reduction in boys with muscular dystrophy. Dev. Med. Child Neurol. 26, 382-390.
30. Eiholzer, U., Boltshauser, E., Frey, D., Molinari, L. & Zachmann, M. (1988) Short stature: A common feature in Duchenne muscular dystrophy. Eur. J. Pediatr. 147, 602-605.
31. Escolar, D., Buyse, G., Henrickson, E., Leshner, R. & Group, A.T.C. (2005) CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann. Neurol. 58, 151-155.
32. Fabbro, F., Marini, A., Felisari, G., Comi, G.P., D'Angelo, M.G., Turconi, A.C. & Bresolin, N. (2007) Language disturbances in a group of participants suffering from Duchenne muscular dystrophy: A pilot study. Percept Mot. Skills 104, 663-676.
33. Fenichel, G.M., Brooke, M.H., Griggs, R.C., Mendell, J.R., Miller, J.P., Moxley, R.T. III, Park, J.H., Provine, M.A., Florence, J., Kaiser, K.K., King, W.M., Pandya, S., Robison, J. & Signore, L. (1988) Clinical investigation in Duchenne muscular dystrophy: Penicillamine and vitamin E. Muscle Nerve 11, 1164-1168.
34. Franciotta, D., Zanardi, M.C., Albertotti, L., Orcesi, S., Berardinelli, A., Pichiecchio, A., Uggetti, C. & Tagliabue, A. (2003) Measurement of skeletal muscle mass in Duchenne muscular dystrophy: Use of 24-h creatinine excretion. Acta Diabetol. 40(Suppl. 1), S290-S2922.
35. Ghafari, J., Clark, R.E., Shofer, F.S. & Berman, P.H. (1988) Dental and occlusal characteristics of children with neuromuscular disease. Am. J. Orthod. Dentofac. Orthop. 93, 126-132.
36. Goldstein, M., Meyer, S. & Freund, H.R. (1989) Effects of overfeeding in children with muscle dystrophies. JPEN J. Parenter. Enteral. Nutr. 13, 603-607.
37. Gong, Q.Y., Phoenix, J., Kemp, G.J., Garcia-Finana, M., Frostick, S.P., Brodie, D.A., Edwards, R.H., Whitehouse, G.H. & Roberts, N. (2000) Estimation of body composition in muscular dystrophy by MRI and stereology. J. Magn. Reson. Imaging 12, 467-475.
38. Gonzalez-Bermejo, J., Lofaso, F., Falaize, L., Lejaille, M., Raphael, J.C., Similowski, T. & Melchior, J.C. (2005) Resting energy expenditure in Duchenne patients using home mechanical ventilation. Eur. Respir. J. 25, 682-687.
39. Grande, B.M. & Graves, B.S. (2005) Creatine supplementation: Forms, function, and effects. Strength Cond. J. 27, 62.
40. Grange, R.W. & Call, J.A. (2007) Recommendations to define exercise prescription for Duchenne muscular dystrophy. Exerc. Sport Sci. Rev. 35, 12-17.
41. Griffiths, R.D. & Edwards, R.H. (1988) A new chart for weight control in Duchenne muscular distrophy. Arch. Dis. Child. 63, 1256-1258.
42. Griggs, R.C., Forbes, G., Moxley, R.T. & Herr, B.E. (1983) The assessment of muscle mass in progressive neuromuscular disease. Neurology 33, 158-165.
43. Hankard, R., Gottrand, F., Turck, D., Carpentier, A., Romon, M. & Farriaux, J.P. (1996a) Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy. Pediatr. Res. 40, 29-33.
44. Hankard, R.G., Haymond, M.W. & Darmaun, D. (1996b) Effect of glutamine on leucine metabolism in humans. Am. J. Physiol. 271, E748-E754.
45. Hankard, R., Hammond, D., Haymond, M. & Darmaun, D. (1998) Oral glutamine slows down whole body protein breakdown in Duchenne muscular dystropy. Pediatr. Res. 43, 222-226.
46. Hankard, R., Mauras, N., Hammond, D., Haymond, M. & Darmaun, D. (1999) Is glutamine a 'conditionally essential' amino acid in Duchenne muscular dystrophy? Clin. Nutr. 18, 365-369.
47. Hilton, T., Orr, R.D., Perkin, R.M. & Ashwal, S. (1993) End of life care in Duchenne muscular dystrophy. Pediatr. Neurol. 9, 165-177.
48. Hinton, V.J., De Vivo, D.C., Nereo, N.E., Goldstein, E. & Stern, Y. (2000) Poor verbal working memory across intellectual level in boys with Duchenne dystrophy. Neurology 54, 2127-2132.
49. Huang, Y., Majumdar, S., Genant, H.K., Chan, W.P., Sharma, K.R., Yu, P., Mynhier, M. & Miller, R.G. (1994) Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J. Magn. Reson. Imaging 4, 59-64.
50. Iannaccone, S.T., Owens, H., Scott, J. & Teitell, B. (2003) Postoperative malnutrition in Duchenne muscular dystrophy. J. Child Neurol. 18, 17-20.
51. Jaffe, K.M., McDonald, C.M., Ingman, E. & Haas, J. (1990) Symptoms of upper gastrointestinal dysfunction in Duchenne muscular dystrophy: case-control study. Arch. Phys. Med. Rehab. 71, 742-744.
52. Kilmer, D.D. & Zhao, H.H. (2005) Obesity, physical activity, and the metabolic syndrome in adult neuromuscular disease. Phys. Med. Rehabil. Clin. N. Am. 16, 1053-1062.
53. Kley, R.A., Vorgerd, M. & Tarnopolsky, M.A. (2007) Creatine for treating muscle disorders (Review). Cochrane Database Syst. Rev. 1, CD004760.
54. Leon, S.H., Schuffler, M.D., Kettler, M. & Rohrmann, C.A. (1986) Chronic intestinal pseudoobstruction as a complication of Duchenne's muscular dystrophy. Gastroenterology 90, 455-459.
55. Leroy-Willig, A., Willig, T.N., Henry-Feugeas, M.C., Frouin, V., Marinier, E., Boulier, A., Barzic, F., Schouman-Claeys, E. & Syrota, A. (1997) Body composition determined with MR in patients with Duchenne muscular dystrophy, spinal muscular atrophy, and normal subjects. Magn. Reson. Imaging 15, 737-744.
56. Louis, M., Lebacq, J., Poortmans, J.R., Belpaire-Dethiou, M.C., Devogelaer, J.P., Van Hecke, P., Goubel, F. & Francaux, M. (2003) Beneficial effects of creatine supplementation in dystrophic patients. Muscle Nerve 27, 604-610.
57. McCrory, M.A., Mole, P.A., Gomez, T.D., Dewey, K.G. & Bernauer, E.M. (1998) Body composition by air-displacement plethysmography by using predicted and measured thoracic gas volumes. J. Appl. Physiol. 84, 1475-1479.
58. McDonald, C. (2002) Physical activity, health impairments, and disability in neuromuscular disease. Am. J. Phys. Med. Rehab. 81, S108-S120.
59. McDonald, C.M., Abresch, R.T., Carter, G.T., Fowler, W.M. Jr, Johnson, E.R., Kilmer, D.D. & Sigford, B.J. (1995) Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am. J. Phys. Med. Rehab. 74, S70-S92.
60. McDonald, C.M., Carter, G.T., Abresch, R.T., Widman, L., Styne, D.M., Warden, N. & Kilmer, D.D. (2005) Body composition and water compartment measurements in boys with Duchenne muscular dystrophy. Am. J. Phys. Med. Rehab. 84, 483-491.
61. Mok, E., Beghin, L., Gachon, P., Daubrosse, C., Fontan, J.E., Cuisset, J.M., Gottrand, F. & Hankard, R. (2006a) Estimating body composition in children with Duchenne muscular dystrophy: Comparison of bioelectrical impedance analysis and skinfold-thickness measurement. Am. J. Clin. Nutr. 83, 65-69.
62. Mok, E., Violante, C., Daubrosse, C., Gottrand, F., Regal, O., Fontan, J.E., Cuisset, J.M., Guilhot, J. & Hankard, R. (2006b) Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy. Am. J. Clin. Nutr. 83, 823-828.
63. Moxley, R.T. III, Ashwal, S., Pandya, S., Connolly, A., Florence, J., Mathews, K., Baumbach, C., McDonald, C., Sussman, M. & Wade, C. (2005) Practice Parameter: Corticosteroid treatment of Duchenne dystrophy: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 64, 13-20.
64. Nagel, B.H.P., Mortier, W., Elmlinger, M., Wollmann, H.A., Schmitt, K. & Ranke, M.B. (1999) Short stature in Duchenne muscular dystrophy: A study of 34 patients. Acta Paediatr. 88, 62-65.
65. Okada, K., Manabe, S., Sakamoto, S., Ohnaka, M. & Niiyama, Y. (1992) Protein and energy metabolism in patients with progressive muscular dystrophy. J. Nutr. Sci. Vitaminol. 38, 141-154.
66. Palmieri, G.M., Bertorini, T.E., Griffin, J.W., Igarashi, M. & Karas, J.G. (1996) Assessment of whole body composition with dual energy x-ray absorptiometry in Duchenne muscular dystrophy: Correlation of lean body mass with muscle function. Muscle Nerve 19, 777-779.
67. Pane, M., Vasta, I., Messina, S., Sorletti, D., Aloysius, A., Sciarra, F., Mangiola, F., Kinali, M., Ricci, E. & Mercuri, E. (2006) Feeding problems and weight gain in Duchenne muscular dystrophy. Eur. J. Paediatr. Neurol. 10, 231-236.
68. Payne, E.T., Yasuda, N., Bourgeois, J.M., Devries, M.C., Rodriguez, M.C., Yousuf, J. & Tarnopolsky, M.A. (2006) Nutritional therapy improves function and complements corticosteroid intervention in mdx mice. Muscle Nerve 33, 66-77.
69. Pessolano, F.A., Suarez, A.A., Monteiro, S.G., Mesa, L., Dubrovsky, A., Roncoroni, A.J. & De Vito, E.L. (2003) Nutritional assessment of patients with neuromuscular diseases. Am. J. Phys. Med. Rehab. 82, 182-185.
70. Phillips, B., Ball, C., Sackett, D., Badenoch, D., Straus, S., Haynes, B. & Dawes, M. (1998) Oxford Centre for Evidence-based Medicine Levels of Evidence. Available at http://www.cebm.net/index.aspx?o=1025.
71. Pichiecchio, A., Uggetti, C., Egitto, M.G., Berardinelli, A., Orcesi, S., Gorni, K.O.T., Zanardi, C. & Tagliabue, A. (2002) Quantitative MR evaluation of body composition in patients with Duchenne muscular dystrophy. Eur. Radiol. 12, 2704-2709.
72. Pradhan, S., Ghosh, D., Srivastava, N.K., Kumar, A., Mittal, B., Pandey, C.M. & Singh, U. (2006) Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation. J. Neurol. 253, 1309-1316.
73. Satomura, S., Yokota, I., Tatara, K., Naito, E., Ito, M. & Kuroda, Y. (2001) Paradoxical weight loss with extra energy expenditure at brown adipose tissue in adolescent patients with Duchenne muscular dystrophy. Metabolism 50, 1181-1185.
74. Söderpalm, A.C., Magnusson, P., Ahlander, A.C., Karlsson, J., Kroksmark, A.K., Tulinius, M. & Swolin-Eide, D. (2007) Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy. Neuromuscul. Disord. 17, 919-928.
75. Sorva, R.A. & Turpeinen, M.T. (1994) Asthma, glucocorticoids and growth. Ann. Med. 26, 309-314.
76. Stewart, L., Mckaig, N., Dunlop, C., Daly, H. & Almond, S. (2006) Guidelines on Dietetic Assessment and Monitoring of Children with Special Needs and Faltering Growth. Birmingham: British Dietetic Association.
77. Strober, J.B. (2000) Genetics of pediatric neuromuscular disease. Curr. Opin. Pediatr. 12, 549-553.
78. Strober, J.B. (2006) Therapeutics in Duchenne muscular dystrophy. NeuroRx 3, 225-234.
79. Tarnopolsky, M.A., Mahoney, D.J., Vajsar, J., Rodriguez, C., Doherty, T.J., Roy, B.D. & Biggar, D. (2004) Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology 62, 1771-1777.
80. Truby, H., Baic, S., Delooy, A., Fox, K.R., Livingstone, M.B.E., Logan, C.M., MacDonald, I.A., Morgan, L.M., Taylor, M.A. & Millward, D.J. (2006) Randomised controlled trial of four commercial weight loss programmes in the UK: Initial findings from the BBC 'diet trials'. Br. Med. J. 332, 1309-1311.
81. Voisin, V., Sebrie, C., Matecki, S., Yu, H., Gillet, B., Ramonatxo, M., Israel, M. & De La Porte, S. (2005) L-arginine improves dystrophic phenotype in mdx mice. Neurobiol. Dis. 20, 123-130.
82. Walter, M.C., Lochmuller, H., Reilich, P., Klopstock, T., Huber, R., Hartard, M., Hennig, M., Pongratz, D. & Muller-Felber, W. (2000) Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study. Neurology 54, 1848-1850.
83. Willig, T.N., Carlier, L., Legrand, M., Riviere, H. & Navarro, J. (1993) Nutritional assessment in Duchenne muscular dystrophy. Dev. Med. Child Neurol. 35, 1074-1082.
84. Willig, T.N., Paulus, J., Lacau Saint Guily, J., Beon, C. & Navarro, J. (1994) Swallowing problems in neuromuscular disorders. Arch. Phys. Med. Rehab. 75, 1175-1181.
85. Yilmaz, O., Karaduman, A. & Topaloglu, H. (2004) Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis. Eur. J. Neurol. 11, 541-544.
86. Zanardi, M.C., Tagliabue, A., Orcesi, S., Berardinelli, A., Uggetti, C. & Pichiecchio, A. (2003) Body composition and energy expenditure in Duchenne muscular dystrophy. Eur. J. Clin. Nutr. 57, 273-278.